[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.193.85. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correction
February 27, 2008

Incorrect Data Reported in Text and Figure in: Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate: A Randomized Controlled Trial

JAMA. 2008;299(8):899-900. doi:10.1001/jama.299.8.899

Incorrect Data Reported in Text and Figure: In the Original Contribution entitled “Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate: A Randomized Controlled Trial” published in the September 14, 2005, issue of JAMA (2005;294[10]:1233-1239), data were incorrectly reported. In the “Results” section of the Abstract on page 1233, the first and second sentences should have read as follows: “The proportions of men free from biochemical failure at 5 years were 78.8% (95% confidence interval, 73.1%-84.6%) for conventional-dose and 91.3% (95% confidence interval, 87.2%-95.4%) for high-dose therapy (P < .001), a 59% reduction in the risk of failure. The advantage to high-dose therapy was statistically significant in the low-risk subgroup (risk reduction, 84% [P < .001]).”

×